Filter Results
:
(2,165)
Show Results For
-
All HBS Web
(7,264)
- Faculty Publications (2,165)
Show Results For
-
All HBS Web
(7,264)
- Faculty Publications (2,165)
Page 1 of
2,165
Results
→
- April 2024
- Article
Pay-As-You-Go Insurance: Experimental Evidence on Consumer Demand and Behavior
By: Raymond Kluender
Pay-as-you-go contracts reduce minimum purchase requirements which may increase market participation. We randomize the introduction and price(s) of a novel pay-as-you-go contract to the California auto insurance market where 17 percent of drivers are uninsured. The...
View Details
Kluender, Raymond. "Pay-As-You-Go Insurance: Experimental Evidence on Consumer Demand and Behavior." Review of Financial Studies 37, no. 4 (April 2024): 1118–1148.
- 2024
- Working Paper
Appropriate Entrepreneurship? The Rise of China and the Developing World
By: Josh Lerner, Junxi Liu, Jacob Moscona and David Yang
Global innovation and entrepreneurship has traditionally been dominated by a handful
of high-income countries, especially the US. This paper investigates the international
consequences of the rise of a new hub for innovation, focusing on the dramatic
growth of...
View Details
Lerner, Josh, Junxi Liu, Jacob Moscona, and David Yang. "Appropriate Entrepreneurship? The Rise of China and the Developing World." Harvard Business School Working Paper, No. 24-061, March 2024.
- March 2024
- Case
Unintended Consequences of Algorithmic Personalization
By: Eva Ascarza and Ayelet Israeli
“Unintended Consequences of Algorithmic Personalization” (HBS No. 524-052) investigates algorithmic bias in marketing through four case studies featuring Apple, Uber, Facebook, and Amazon. Each study presents scenarios where these companies faced public criticism for...
View Details
Keywords:
Race;
Gender;
Marketing;
Diversity;
Customer Relationship Management;
Technology Industry;
Retail Industry;
United States
Ascarza, Eva, and Ayelet Israeli. "Unintended Consequences of Algorithmic Personalization." Harvard Business School Case 524-052, March 2024.
- March 2024
- Background Note
Physical Climate Risk
By: Michael W. Toffel, Spencer Glendon and Alison Smart
This note describes how managers can identify their company’s physical climate risks, which can heighten the risk of business disruption, change the costs of operations and supply chains, and affect the demand for their goods and services. The note also provides a...
View Details
Keywords:
Climate Change;
Adaptation;
Resilience;
Maps;
Climate Risk;
Climate Impact;
Modeling And Analysis
- March 2024
- Article
Do Safety Management System Standards Indicate Safer Operations? Evidence from the OHSAS 18001 Occupational Health and Safety Standard
By: Kala Viswanathan, Matthew S. Johnson and Michael W. Toffel
Problem definition: Given the enormous disruptions and costs of occupational injuries, companies and buyers are increasingly looking to voluntary occupational health and safety standards to improve worker safety. Yet because these standards only require...
View Details
Keywords:
Occupational Health;
Occupational Safety;
Program Evaluation;
Safety Performance;
Injuries;
OHSAS 18001;
ISO 45001;
Working Conditions;
Safety;
Standards
Viswanathan, Kala, Matthew S. Johnson, and Michael W. Toffel. "Do Safety Management System Standards Indicate Safer Operations? Evidence from the OHSAS 18001 Occupational Health and Safety Standard." Art. 106383. Safety Science 171 (March 2024).
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that...
View Details
Keywords:
Policy;
Government Legislation;
Health Care and Treatment;
Negotiation;
Price;
Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- March 2024
- Article
The Asymmetric Mispricing Information in Analysts’ Target Prices
By: Jeremiah Green, John R. M. Hand and Anywhere Sikochi
We study the mispricing information present in the target prices of U.S. and international analysts. We hypothesize that asymmetry in the value-relevance of the information that managers supply to analysts, combined with asymmetry in the incentives facing analysts to...
View Details
Keywords:
Analysts;
Target Prices;
Mispricing;
Cost Of Equity;
Valuation;
Price;
Cost;
Analysis;
Theory
Green, Jeremiah, John R. M. Hand, and Anywhere Sikochi. "The Asymmetric Mispricing Information in Analysts’ Target Prices." Review of Accounting Studies 29, no. 1 (March 2024): 889–915.
- 2024
- Working Paper
Corporate Culture Homogeneity and Top Executive Incentive Design: Evidence from CEO Compensation Contracts
By: Dennis Campbell, Ruidi Shang and Zhifang Zhang
We examine how corporate cultures characterized by high degrees of homogeneity in the underlying values and beliefs of organizational members are related to the design of CEO incentive compensation contracts. We argue that culture homogeneity within firms lowers...
View Details
Keywords:
Corporate Culture;
Compensation Design;
Accounting;
Management Control;
Incentive Systems;
Organizational Culture;
Job Design and Levels;
Governance;
Executive Compensation;
Motivation and Incentives
Campbell, Dennis, Ruidi Shang, and Zhifang Zhang. "Corporate Culture Homogeneity and Top Executive Incentive Design: Evidence from CEO Compensation Contracts." Harvard Business School Working Paper, No. 24-054, February 2024.
- February 2024
- Article
Representation and Extrapolation: Evidence from Clinical Trials
By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
This article examines the consequences and causes of low enrollment of Black patients in clinical
trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is
more relevant for decision-making by physicians and patients when it...
View Details
Keywords:
Representation;
Racial Disparity;
Health Testing and Trials;
Race;
Equality and Inequality;
Innovation and Invention;
Pharmaceutical Industry
Alsan, Marcella, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein, and Heidi L. Williams. "Representation and Extrapolation: Evidence from Clinical Trials." Quarterly Journal of Economics 139, no. 1 (February 2024): 575–635.
- January 2024
- Case
Frank Cornelissen: The Great Sulfite Debate (A)
By: Tiona Zuzul and Susan Pinckney
In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between staying true to the tenets of the natural wine...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Agribusiness;
Plant-Based Agribusiness;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication Strategy;
Decision Making;
Cost vs Benefits;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Globalization;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Strategy;
Adaptation;
Expansion;
Food and Beverage Industry;
Europe;
Italy
Zuzul, Tiona, and Susan Pinckney. "Frank Cornelissen: The Great Sulfite Debate (A)." Harvard Business School Case 724-391, January 2024.
- January 2024
- Teaching Note
Frank Cornelissen: The Great Sulfite Debate (A) & (B)
By: Tiona Zuzul
Teaching Note for HBS Case Nos. 724-391 and 724-398. In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Agribusiness;
Plant-Based Agribusiness;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication Strategy;
Decision Making;
Cost vs Benefits;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Globalization;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Strategy;
Adaptation;
Expansion;
Food and Beverage Industry;
Europe;
Italy
- January 2024
- Supplement
Frank Cornelissen: The Great Sulfite Debate (B)
By: Tiona Zuzul and Susan Pinckney
In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between staying true to the tenets of the natural wine...
View Details
Keywords:
Budgets and Budgeting;
Business Earnings;
Agribusiness;
Plant-Based Agribusiness;
Business Startups;
Family Business;
For-Profit Firms;
Small Business;
Change Management;
Transition;
Communication;
Decision Making;
Cost vs Benefits;
Decisions;
Entrepreneurship;
Environmental Sustainability;
Values and Beliefs;
Financial Management;
Financial Strategy;
Profit;
Revenue;
Spending;
Globalization;
Global Strategy;
Goods and Commodities;
Innovation Strategy;
Crisis Management;
Goals and Objectives;
Growth Management;
Success;
Strategic Planning;
Problems and Challenges;
Risk and Uncertainty;
Cognition and Thinking;
Reputation;
Strategy;
Adoption;
Expansion;
Food and Beverage Industry;
Europe;
Italy
Zuzul, Tiona, and Susan Pinckney. "Frank Cornelissen: The Great Sulfite Debate (B)." Harvard Business School Supplement 724-398, January 2024.
- January 19, 2024
- Article
Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder
By: Robert S. Kaplan and Sarah E. Wakeman
U.S. overdose deaths currently exceed 100,000 per year. New facilities, known as bridge clinics, are broadening access to high-quality care by offering outpatient substance use disorder (SUD) treatment with few access barriers. But many of the critical services offered...
View Details
Kaplan, Robert S., and Sarah E. Wakeman. "Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder." Health Affairs Forefront (January 19, 2024).
- 2024
- Working Paper
Antitrust Platform Regulation and Entrepreneurship: Evidence from China
By: Ke Rong, D. Daniel Sokol, Di Zhou and Feng Zhu
Many jurisdictions have launched antitrust enforcement and brought in regulation of large tech platforms. The swift and strict implementation of China’s Anti-Monopoly Guidelines for the Platform Economy (Platform Guidelines) provides a quasi-natural experiment...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Competition;
Venture Capital;
Market Entry and Exit;
Supply and Industry;
China
Rong, Ke, D. Daniel Sokol, Di Zhou, and Feng Zhu. "Antitrust Platform Regulation and Entrepreneurship: Evidence from China." Harvard Business School Working Paper, No. 24-039, January 2024.
- 2024
- Working Paper
The Value of Open Source Software
By: Manuel Hoffmann, Frank Nagle and Yanuo Zhou
The value of a non-pecuniary (free) product is inherently difficult to assess. A pervasive
example is open source software (OSS), a global public good that plays a vital role in the economy
and is foundational for most technology we use today. However, it is...
View Details
Hoffmann, Manuel, Frank Nagle, and Yanuo Zhou. "The Value of Open Source Software." Harvard Business School Working Paper, No. 24-038, January 2024.
- January 11, 2024
- Article
Understanding the Tradeoffs of the Amazon Antitrust Case
By: Chiara Farronato, Andrey Fradkin, Andrei Hagiu and Dionne Lomax
Regulators in the United States and Europe have been taking on Big Tech, challenging what they say are the companies’ anti-competitive and predatory strategies that harm consumers and third-party users of their platforms. This article examines the FTC’s case against...
View Details
Keywords:
Monopoly;
Governing Rules, Regulations, and Reforms;
Market Design;
Lawsuits and Litigation
Farronato, Chiara, Andrey Fradkin, Andrei Hagiu, and Dionne Lomax. "Understanding the Tradeoffs of the Amazon Antitrust Case." Harvard Business Review Digital Articles (January 11, 2024).
- January 2024
- Supplement
Accounting Red Flags or Red Herrings at Catalent? (B)
By: Joseph Pacelli, ZeSean Ali and Tom Quinn
GlassHouse Research identified accounting red flags at Catalent. Fiat Lux Partners countered most of GlassHouse’s claims. Who was right? This update explores the aftermath of the short seller duel.
View Details
Keywords:
Accounting Audits;
Acquisition;
Budgets and Budgeting;
Business Earnings;
Earnings Management;
Cost Accounting;
Fair Value Accounting;
Financial Reporting;
Revenue Recognition;
Integrated Corporate Reporting;
Fairness;
Moral Sensibility;
Values and Beliefs;
Government Legislation;
Conflict of Interests;
Announcements;
Blogs;
Debates;
Lawsuits and Litigation;
Stocks;
Performance Productivity;
Pharmaceutical Industry;
Accounting Industry;
United States
- January 2024
- Article
A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder
By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with...
View Details
Wakeman, Sarah E., Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe, and Robert S. Kaplan. "A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder." Journal of Behavioral Health Services & Research 51, no. 1 (January 2024): 22–30.
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 2024
- Working Paper
Lost in Transmission
By: Thomas Graeber, Shakked Noy and Christopher Roth
For many decisions, people rely on information received from others by word of mouth. How does the process of verbal transmission distort economic information? In our experiments, participants listen to audio recordings containing economic forecasts and are paid to...
View Details
Keywords:
Information Trnasmission;
Word Of Mouth;
Word-of-Mouth;
Narratives;
Reliability;
Knowledge Sharing;
Spoken Communication;
Cognition and Thinking
Graeber, Thomas, Shakked Noy, and Christopher Roth. "Lost in Transmission." Harvard Business School Working Paper, No. 24-047, January 2024.